Shareholders of Inspire Medical Systems, Inc. Urged to Act as Filing Deadline Looms | CSIMarket News

Shareholders of Inspire Medical Systems, Inc. Urged to Act as Filing Deadline Looms

Published | Modified
CSIMarket Newsroom | CSIMarket.com
Illustrative image

FILING DEADLINE APPROACHING: Shareholders of Inspire Medical Systems, Inc.Encouraged to Take Action

In recent news, Kuznicki Law PLLC has alerted shareholders of Inspire Medical Systems, Inc.(NYSE: INSP) to take immediate action with regards to a class action lawsuit.Shareholders who purchased the company’s shares between May 3, 2023, and November 7, 2023, are advised to file lead plaintiff applications in order to participate in the securities class action lawsuit.The deadline for filing such applications is February 20, 2024.

Additionally, ClaimsFiler, a free shareholder information service, has issued a reminder to investors with losses exceeding $100,000.They too have until February 20, 2024, to file lead plaintiff applications in the securities class action lawsuit against Inspire Medical Systems, Inc.This lawsuit is pending in the United States District Court for the District of Minnesota.

Further compounding the legal issues surrounding Inspire Medical Systems, Inc. Saxena White P.A.has filed a securities fraud class action lawsuit against the company.The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities and Exchange Act of 1934 and U.S.Securities and Exchange Commission Rule 10b-5.The class action is on behalf of all individuals or entities who purchased Inspire Medical’s common stock between May 3, 2023, and November 7, 2023, claiming damages incurred during this period.The lawsuit

Source for this article: Based on Inspire Medical Systems inc ’s official statement
For details on how CSIMarket validates financial and corporate news, please review our Editorial Standards & Fact-Checking Policy .
Tags:
#ClassAction, #ClassAction, #stock, #ClassAction, #Law&LegalIssues, #INSP, #Inspire Medical Systems inc, #
Share this article:
Link copied to clipboard.

Comments

Comments are available to active subscribers. Subscribe or Log in.
Get the full CSIMarket dataset: Subscribe API License